SANGAMO THERAPEUTICS, INC (SGMOQ)
OTC: SGMOQ · CIK 0001001233 · United States
Every official SANGAMO THERAPEUTICS, INC filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open SGMOQ filings
SANGAMO THERAPEUTICS, INC documents
- SANGAMO THERAPEUTICS, INC 10-K 2026SGMOQ 10-K 2026: annual report for fiscal 2026
- SANGAMO THERAPEUTICS, INC 10-K 2025SGMOQ 10-K 2025: annual report for fiscal 2025
- SANGAMO THERAPEUTICS, INC 10-K 2024SGMOQ 10-K 2024: annual report for fiscal 2024
- SANGAMO THERAPEUTICS, INC 10-K 2023SGMOQ 10-K 2023: annual report for fiscal 2023
- SANGAMO THERAPEUTICS, INC 10-K 2022SGMOQ 10-K 2022: annual report for fiscal 2022
- SANGAMO THERAPEUTICS, INC 10-Q 2026SGMOQ 10-Q 2026: quarterly report for fiscal 2026
- SANGAMO THERAPEUTICS, INC 10-Q 2025SGMOQ 10-Q 2025: quarterly report for fiscal 2025
- SANGAMO THERAPEUTICS, INC 10-Q 2024SGMOQ 10-Q 2024: quarterly report for fiscal 2024
- SANGAMO THERAPEUTICS, INC 10-Q 2023SGMOQ 10-Q 2023: quarterly report for fiscal 2023
- SANGAMO THERAPEUTICS, INC 10-Q 2022SGMOQ 10-Q 2022: quarterly report for fiscal 2022
- SANGAMO THERAPEUTICS, INC 8-K 2026SGMOQ 8-K 2026: current report for fiscal 2026
- SANGAMO THERAPEUTICS, INC 8-K 2025SGMOQ 8-K 2025: current report for fiscal 2025
- SANGAMO THERAPEUTICS, INC 8-K 2024SGMOQ 8-K 2024: current report for fiscal 2024
- SANGAMO THERAPEUTICS, INC 8-K 2023SGMOQ 8-K 2023: current report for fiscal 2023
- SANGAMO THERAPEUTICS, INC 8-K 2022SGMOQ 8-K 2022: current report for fiscal 2022
- SANGAMO THERAPEUTICS, INC DEF 14A 2026SGMOQ DEF 14A 2026: proxy statement for fiscal 2026
- SANGAMO THERAPEUTICS, INC DEF 14A 2025SGMOQ DEF 14A 2025: proxy statement for fiscal 2025
- SANGAMO THERAPEUTICS, INC DEF 14A 2024SGMOQ DEF 14A 2024: proxy statement for fiscal 2024
- SANGAMO THERAPEUTICS, INC DEF 14A 2023SGMOQ DEF 14A 2023: proxy statement for fiscal 2023
- SANGAMO THERAPEUTICS, INC DEF 14A 2022SGMOQ DEF 14A 2022: proxy statement for fiscal 2022
- SANGAMO THERAPEUTICS, INC Form 4 2026SGMOQ Form 4 2026: insider trading filing for fiscal 2026
- SANGAMO THERAPEUTICS, INC Form 4 2025SGMOQ Form 4 2025: insider trading filing for fiscal 2025
- SANGAMO THERAPEUTICS, INC Form 4 2024SGMOQ Form 4 2024: insider trading filing for fiscal 2024
- SANGAMO THERAPEUTICS, INC Form 4 2023SGMOQ Form 4 2023: insider trading filing for fiscal 2023
- SANGAMO THERAPEUTICS, INC Form 4 2022SGMOQ Form 4 2022: insider trading filing for fiscal 2022
- SANGAMO THERAPEUTICS, INC S-1 2026SGMOQ S-1 2026: registration statement for fiscal 2026
- SANGAMO THERAPEUTICS, INC S-1 2025SGMOQ S-1 2025: registration statement for fiscal 2025
- SANGAMO THERAPEUTICS, INC S-1 2024SGMOQ S-1 2024: registration statement for fiscal 2024
- SANGAMO THERAPEUTICS, INC S-1 2023SGMOQ S-1 2023: registration statement for fiscal 2023
- SANGAMO THERAPEUTICS, INC S-1 2022SGMOQ S-1 2022: registration statement for fiscal 2022
- SANGAMO THERAPEUTICS, INC 13F 2026SGMOQ 13F 2026: institutional holdings for fiscal 2026
- SANGAMO THERAPEUTICS, INC 13F 2025SGMOQ 13F 2025: institutional holdings for fiscal 2025
- SANGAMO THERAPEUTICS, INC 13F 2024SGMOQ 13F 2024: institutional holdings for fiscal 2024
- SANGAMO THERAPEUTICS, INC 13F 2023SGMOQ 13F 2023: institutional holdings for fiscal 2023
- SANGAMO THERAPEUTICS, INC 13F 2022SGMOQ 13F 2022: institutional holdings for fiscal 2022
More companies